Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Clinical trial NCT06326034 · COMPLETED
Trial details
- NCT number
- NCT06326034
- Sponsor
- Mohammed Mahmood Mohammed
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.